Randomized phase II trial of gemcitabine and either day 1 or day 8 carboplatin for advanced non-small-cell lung cancer: Is thrombocytopenia predictable?

Cathy Crombie, W Burns, Christos Karapetis, R Lowenthal, Fred Kirsten, J Davidson, Fiona Abell, William Reece, Jose Iglesias, Paul De Souza

    Research output: Contribution to journalArticle

    Original languageEnglish
    Pages (from-to)24-31
    Number of pages8
    JournalAsia-Pacific Journal of Clinical Oncology
    Volume5
    Issue number1
    Publication statusPublished - 2009

    Cite this

    Crombie, C., Burns, W., Karapetis, C., Lowenthal, R., Kirsten, F., Davidson, J., Abell, F., Reece, W., Iglesias, J., & De Souza, P. (2009). Randomized phase II trial of gemcitabine and either day 1 or day 8 carboplatin for advanced non-small-cell lung cancer: Is thrombocytopenia predictable? Asia-Pacific Journal of Clinical Oncology, 5(1), 24-31.